Trial Profile
A study to evaluate the effects of Azilsartan medoxomil on blood pressure control and plasma aldosterone concentration by switching from other angiotensin receptor blockers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Azilsartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 14 Nov 2016 New trial record
- 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension